Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival
Lunde, L E, Dasaraju, S, Cao, Q, Cohn, C S, Reding, M, Bejanyan, N, Trottier, B, Rogosheske, J, Brunstein, C, Warlick, E, Young, J A H, Weisdorf, D J, Ustun, C
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Get full text
Journal Article
Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival
ROGOSHESKE, J. R, FARGEN, A. D, DEFOR, T. E, WARLICK, E, ARORA, M, BLAZAR, B. R, WEISDORF, D. J, BRUNSTEIN, C. G
Published in Bone marrow transplantation (Basingstoke) (01.01.2014)
Published in Bone marrow transplantation (Basingstoke) (01.01.2014)
Get full text
Journal Article
Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation
BEJANYAN, N, ORAN, B, SHANLEY, R, WARLICK, E, USTUN, C, VERCELLOTTI, G, VERNERIS, M, WAGNER, J. E, WEISDORF, D, BRUNSTEIN, C
Published in Bone marrow transplantation (Basingstoke) (01.08.2014)
Published in Bone marrow transplantation (Basingstoke) (01.08.2014)
Get full text
Journal Article
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD
He, F, Warlick, E, Miller, J S, MacMillan, M, Verneris, M R, Cao, Q, Weisdorf, D
Published in Bone marrow transplantation (Basingstoke) (01.08.2016)
Published in Bone marrow transplantation (Basingstoke) (01.08.2016)
Get full text
Journal Article
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D
Published in Bone marrow transplantation (Basingstoke) (01.04.2017)
Published in Bone marrow transplantation (Basingstoke) (01.04.2017)
Get full text
Journal Article
Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML
Ustun, C, Wiseman, A C, Defor, T E, Yohe, S, Linden, M A, Oran, B, Burke, M, Warlick, E, Miller, J S, Weisdorf, D
Published in Bone marrow transplantation (Basingstoke) (01.11.2013)
Published in Bone marrow transplantation (Basingstoke) (01.11.2013)
Get full text
Journal Article
Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation
Ustun, C, Brunstein, C, DeFor, T, Rashidi, A, Yohe, S, Bejanyan, N, Cooley, S, Warlick, E, Miller, J, Linden, M A, Weisdorf, D
Published in Bone marrow transplantation (Basingstoke) (01.01.2018)
Published in Bone marrow transplantation (Basingstoke) (01.01.2018)
Get full text
Journal Article
Reduced-intensity hematopoietic cell transplantation in older patients with AML MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors
Majhail, N S, Brunstein, C G, Shanley, R, Sandhu, K, McClune, B, Oran, B, Warlick, E D, Wagner, J E, Weisdorf, D J
Published in Bone marrow transplantation (Basingstoke) (01.04.2012)
Published in Bone marrow transplantation (Basingstoke) (01.04.2012)
Get full text
Journal Article
Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation
BURKE, M. J, GOSSAI, N, CAO, Q, MACMILLAN, M. L, WARLICK, E, VERNERIS, M. R
Published in Bone marrow transplantation (Basingstoke) (01.02.2014)
Published in Bone marrow transplantation (Basingstoke) (01.02.2014)
Get full text
Journal Article
55 IN VIVO OLIGOCLONAL T-CELL EXPANSION AND SPECIFIC IN VITRO T-CELL RESPONSES FOLLOWING K562/GM-CSF VACCINATION OF MDS PATIENTS
Prince, G, Thoburn, C, Warlick, E, Hess, A, Levitsky, H, Smith, B.D
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P492: TAMIBAROTENE IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN PREVIOUSLY UNTREATED ADULT PATIENTS SELECTED FOR RARA‐POSITIVE AML WHO ARE INELIGIBLE FOR STANDARD INDUCTION THERAPY (SELECT AML‐1)
Stein, E., Botton, S., Pigneux, A., McMahon, C., Ball, B., Borthakur, G., Eghtedar, A., Kambhampati, S., Tache, J., Wang, E., Kelley, H., Volkert, A., Baker, K., Kang‐Fortner, Q., Hodgson, G., Madigan, C., Warlick, E., Roth, D., Kelly, M., Pollyea, D.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Mechanistic Diversity in the RuBisCO Superfamily: RuBisCO from Rhodospirillum rubrum Is Not Promiscuous for Reactions Catalyzed by RuBisCO-like Proteins
Warlick, Benjamin P. E, Imker, Heidi J, Sriram, Jaya, Tabita, F. Robert, Gerlt, John A
Published in Biochemistry (Easton) (27.11.2012)
Published in Biochemistry (Easton) (27.11.2012)
Get full text
Journal Article